Italia markets open in 1 hour 23 minutes

HCW Biologics Inc. (HCWB)

NasdaqGM - NasdaqGM Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,7870-0,0132 (-1,65%)
Alla chiusura: 04:00PM EDT
0,7749 -0,01 (-1,54%)
Dopo ore: 06:39PM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente0,8002
Aperto0,7780
Denaro0,0000 x 0
Domanda0,0000 x 0
Min-Max giorno0,7100 - 0,8500
Intervallo di 52 settimane0,7100 - 2,3200
Volume51.037
Media Volume19.378
Capitalizzazione29,767M
Beta (mensile su 5 anni)0,94
Rapporto PE (ttm)N/D
EPS (ttm)-0,7600
Prossima data utiliN/D
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendoN/D
Stima target 1A4,00
  • GlobeNewswire

    HCW Biologics Participating at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11 – 13, 2023

    Company will provide an update for clinical development and intellectual property programs, Including recent achievements and expected milestones in the next 12 monthsMIRAMAR, Fla., Sept. 06, 2023 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and age-related diseases, will participate

  • GlobeNewswire

    HCW Biologics Reports Second Quarter 2023 Financial Results and Recent Business Highlights

    MIRAMAR, Fla., Aug. 11, 2023 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and age-related diseases, today reported financial results and recent business highlights for its second quarter ended June 30, 2023. “During the period ended June 30, 2023, we have made significant progress in